Induction chemotherapy for head and neck cancer: is there still a role?


Integration and optimization of active systemic agents and radiosensitizers into the therapeutic regimen for head and neck cancer remains a topic of active investigation. Recent trials have not consistently supported the use of induction chemotherapy. There are several clinical scenarios in which there is a strong rationale for induction chemotherapy, such… (More)
DOI: 10.2217/fon-2016-0073